A Clinical Evaluation of Lifitegrast Ophthalmic Solution 5% in Symptomatic Contact Lens Wearers.

Schulze MM, Guthrie SE, Ho B, Woods J, Jones L

Open source

DOI
10.2147/opth.s538184
Published
2025
Container
Clinical ophthalmology (Auckland, N.Z.)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/opth.s538184,
  title = {A Clinical Evaluation of Lifitegrast Ophthalmic Solution 5\% in Symptomatic Contact Lens Wearers.},
  author = {Schulze MM and Guthrie SE and Ho B and Woods J and Jones L},
  year = {2025},
  journal = {Clinical ophthalmology (Auckland, N.Z.)},
  doi = {10.2147/opth.s538184},
  url = {https://doi.org/10.2147/opth.s538184}
}

RIS

TY  - JOUR
TI  - A Clinical Evaluation of Lifitegrast Ophthalmic Solution 5% in Symptomatic Contact Lens Wearers.
AU  - Schulze MM
AU  - Guthrie SE
AU  - Ho B
AU  - Woods J
AU  - Jones L
PY  - 2025
JO  - Clinical ophthalmology (Auckland, N.Z.)
DO  - 10.2147/opth.s538184
UR  - https://doi.org/10.2147/opth.s538184
ER  - 

APA

MM, S., SE, G., B, H., J, W., & L, J. (2025). A Clinical Evaluation of Lifitegrast Ophthalmic Solution 5% in Symptomatic Contact Lens Wearers.. Clinical ophthalmology (Auckland, N.Z.). https://doi.org/10.2147/opth.s538184

Source records